Leptomeningeal Disease (LMD): Clinical Trials

3 trials for Leptomeningeal Disease (LMD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 2 Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Not applicable1Recruiting 1

Follow Leptomeningeal Disease (LMD): new trials by email Literature Review of Leptomeningeal Disease (LMD) trials Research Report on Leptomeningeal Disease (LMD)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal Disease
SX-682, Proton Craniospinal Irradiation (pCSI) - Leptomeningeal Disease (LMD)
Phase 1RecruitingMemorial Sloan Kettering Cancer Center402026-09-042026-09-11
Exploring the Feasibility of Cerebrospinal Fluid (CSF) and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and Primary Central Nervous System (CNS) Tumours: A Pilot Study
One time CSF and blood sample - Solid Tumor Malignancies, Brain Metastasases
Not applicableRecruitingSunnybrook Health Sciences Centre602025-12-122026-07-31
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Radiation Therapy, AZD1390 - Recurrent Glioblastoma Multiforme, Primary Glioblastoma Multiforme
Phase 1CompletedAstraZeneca1592018-04-022026-10-15

Narrower conditions

Meningeal Neoplasms (3)  ·  Brain Neoplasms (1)  ·  Glioblastoma (1)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  Inhibition, Psychological (1)

Broader conditions

Central Nervous System Neoplasms (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Nervous System Diseases (3)  ·  Nervous System Neoplasms (3)  ·  Astrocytoma (1)  ·  Behavior (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Glioma (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Neoplasms by Histologic Type (1)

Interventions

AZD1390 (1)  ·  Blood Specimen Collection (1)  ·  Radiotherapy (1)

Sponsors

AstraZeneca (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Sunnybrook Health Sciences Centre (1)

Countries

United States (2)  ·  Canada (1)  ·  Japan (1)  ·  United Kingdom (1)

Top investigators

Anthony Chalmers (1)  ·  Brandon Imber (1)  ·  Deborah Forst (1)  ·  Jan Drappatz (1)  ·  Kazuhiko Mishima (1)  ·  Louise Murray (1)  ·  Mariza Daras (1)  ·  Monica Chen, MD (1)  ·  Patrick Wen (1)  ·  Rajesh Jena (1)  ·  Yoshiki Arakawa (1)  ·  Yoshitaka Narita (1)

NIH funding

2017 (1)